Gracias a esta Postgraduate diploma 100% online, planificarás terapias altamente personalizadas para el manejo de la Patología Infecciosa y Uveítis de la Mácula, Retina y Vítreo” 

Las Infecciones y la Uveítis del Segmento Posterior son causas significativas de pérdida visual global. Según la Organización Mundial de la Salud, más de 2.2 mil millones de personas presentan algún tipo de Discapacidad Visual, y un porcentaje importante se relaciona con Patologías Vitreorretinianas. Por ello, la evaluación precisa mediante instrumentos como la angiografía fluoresceínica y los estudios microbiológicos es esencial para un manejo individualizado. En este contexto, los facultativos precisan dominar técnicas avanzadas de diagnóstico y seguimiento clínico, así como planificar tratamientos antimicrobianos y antiinflamatorios personalizados según la etiología de la enfermedad. 

En este marco, TECH lanza un pionero Postgraduate diploma en Infectious Pathology and Uveitis of the Macula, Retina and Vitreous. Confeccionado por verdaderas referencias en este ámbito, el plan de estudios ahondará en los principios del diagnóstico de las enfermedades más prevalentes que afectan al segmento posterior del ojo. En este sentido, el temario profundizará en la interpretación precisa de pruebas imagenológicas como la angiografía fluoresceínica. Además, los materiales didácticos ofrecerán técnicas innovadoras para planificar tratamientos personalizados, monitorizar la evolución clínica y prevenir complicaciones. De esta forma, los egresados desarrollarán competencias avanzadas para ofrecer una atención oftalmológica integral, segura y basada en evidencia científica. 

Cabe destacar que esta opción académica se imparte mediante la disruptiva metodología del Relearning, consistente en la reiteración natural y progresiva de los aspectos más relevantes. De este modo, los médicos no tienen que invertir exhaustivas horas al estudio o recurrir a métodos tradicionales como la memorización. A su vez, tan solo necesitarán un dispositivo electrónico capaz de conectarse a internet para acceder al Campus Virtual. En esta plataforma, encontrarán una variedad de píldoras multimedia como vídeos en detalle, lecturas especializadas o ejercicios prácticos en entornos simulados. Adicionalmente, un prestigioso Director Invitado Internacional ofrecerá unas rigurosas Masterclasses. 

Un reputado Director Invitado Internacional brindará unas intensivas Masterclasses sobre los últimos avances en el abordaje de la Patología Infecciosa y Uveítis” 

Esta Postgraduate diploma en Infectious Pathology and Uveitis of the Macula, Retina and Vitreous contiene el programa universitario más completo y actualizado del mercado. Sus características más destacadas son: 

• El desarrollo de casos prácticos presentados por expertos en Medicina 
• Los contenidos gráficos, esquemáticos y eminentemente prácticos con los que están concebidos recogen una información científica y práctica sobre aquellas disciplinas indispensables para el ejercicio profesional 
• Los ejercicios prácticos donde realizar el proceso de autoevaluación para mejorar el aprendizaje 
• Su especial hincapié en metodologías innovadoras 
• Las lecciones teóricas, preguntas al experto, foros de discusión de temas controvertidos y trabajos de reflexión individual 
• La disponibilidad de acceso a los contenidos desde cualquier dispositivo fijo o portátil con conexión a internet 

Con el sistema Relearning no tendrás que invertir una gran cantidad de horas de estudio y te focalizarás en los conceptos más relevantes” 

Incluye en su cuadro docente a profesionales pertenecientes al ámbito de la Medicina, que vierten en este programa la experiencia de su trabajo, además de reconocidos especialistas de sociedades de referencia y universidades de prestigio.

Su contenido multimedia, elaborado con la última tecnología educativa, permitirá al profesional un aprendizaje situado y contextualizado, es decir, un entorno simulado que proporcionará un estudio inmersivo programado para entrenarse ante situaciones reales.

El diseño de este programa se centra en el Aprendizaje Basado en Problemas, mediante el cual el alumno deberá tratar de resolver las distintas situaciones de práctica profesional que se le planteen a lo largo del curso académico. Para ello, el profesional contará con la ayuda de un novedoso sistema de vídeo interactivo realizado por reconocidos expertos.

Abordarás los fundamentos anatómicos y fisiopatológicos del segmento posterior del ojo” 

Integrarás estrategias innovadoras para mejorar la atención oftalmológica de manera significativa” 

The structure of the syllabus has been designed by a team of professionals who are knowledgeable regarding the implications of medical education in the approach to patients, aware of the relevance of current preparation and committed to quality teaching through new educational technologies. 

This Postgraduate diploma contains the most complete and up-to-date scientific program on the market”

Module 1. Anatomy, Physiology and Exploratory and Functional Tests

1.1. Historical Notes and Classical Exploration in Consultation

1.1.1. History to Understand the Present
1.1.2. The Ophthalmoscope and its Examination Lenses
1.1.3. The Slit Lamp and its Examination Lenses
1.1.4. Historical Notes of Current Exploration Techniques

1.2. Macula and Retina Atanomy

1.2.1. Compared Anatomy
1.2.2. Macula and Retinal Histology
1.2.3. Vascularisation of the Retina and Macula
1.2.4. Innervation of the Retina and Macula

1.3. Vitreous anatomy and Physiology

1.3.1. Vitreous Embryology
1.3.2. Composition of the Vitreous Gel
1.3.3. Hyaloid Insertions and Adhesions
1.3.4. Ageing and Alterations of the Vitreous Gel
1.3.5. The Vitreous in Myopic Patients
1.3.6. The Vitreous in Certain Systemic Diseases
1.3.7. Vitreous as a Trigger for Various Retinal and Macular Pathologies

1.4. Physiology of Vision and Colour Vision

1.4.1. Functional Layers of the Retina
1.4.2. Photoreceptor Physiology
1.4.3. Functional Circuits of the Retina
1.4.4. Optical Route
1.4.5. Physiology of the Visual Cortex
1.4.6. Binocularity
1.4.7. Colour Vision

1.5. Macular Functional Testing

1.5.1. Basis of Macular Functional Testing
1.5.2. Electroretinogram, Electrooculogram and Evoked Potentials
1.5.3. Multifocal Electroretinogram
1.5.4. Microperimetry

1.6. Fundus Photography, Intravenous Fluorescein Angiography and Indocyanine Green Angiography

1.6.1. Analogue and Digital Retinography
1.6.2. Widefield Retinography, Most Important Current Platforms
1.6.3. Properties of Sodium Fluorescein and its Adverse Effects
1.6.4. Normal AFG Pattern (Angiofluoresceingraphy)
1.6.5. Pathological Angiographic Patterns, Hyperfluorescence, Hypofluorescence and Window Effect
1.6.6. Current Role and Clinical Indications of AFG
1.6.7. Properties of Indocyanine Green and its Pharmacokinetics
1.6.8. Pathological Angiographic Patterns of Indocyanine Green

1.7. Fundus Autofluorescence

1.7.1. Autofluorescence Detection and Recording
1.7.2. Autofluorescence Detection and Recording
1.7.3. Normal Autofluorescence Patterns
1.7.4. Pathologic Autofluorescence Patterns
1.7.5. Autofluorescence in Retinal Diseases

1.8. Ultrasonic Retinal Evaluation

1.8.1. Physical Bases of Ultrasound
1.8.2. Current Platforms and Probes for Ocular Ultrasound Scans
1.8.3. Current Ultrasound Methods and Modes
1.8.4. Ocular Ultrasound Patterns

1.9. Optical Coherence Tomography

1.9.1. Physical Principles of OCT (Optical Coherence Tomography)
1.9.2. Historical Evolution of OCT
1.9.3. Main OCT Platforms and Their Differential Characteristics
1.9.4. Normal OCT Patterns
1.9.5. Comparative Patterns of OCT Monitoring
1.9.6. OCT in Major Macular and Interface Pathologies

1.10. Angiography Using Optical Coherence Tomography

1.10.1. Basis of OCT Angiography
1.10.2. Main Platforms for Performing Angio OCT
1.10.3. Normal OCT Angiographic Patterns
1.10.4. Analysis and Artifacts in OCT Angiography
1.10.5. AngioOCT in the Main Macular Pathologies
1.10.6. Clinical Angio OCT in Face
1.10.7. Present and Future of Angio OCT

Module 2. Inflammatory Eye Diseases with Affectation of Macula, Retina and Vitreous

2.1. Diagnosis and Treatment of Uveitis

2.1.1. Diagnosis of Uveitis

2.1.1.1. Systematic Approach to the Diagnosis of Uveitis
2.1.1.2. Classification of Uveitis
2.1.1.3. Localisation of Uveitis
2.1.1.4. Approach to Patients, The clinical History as a Diagnostic Asset
2.1.1.5. Detailed Eye Examination. Diagnostic Guidance
2.1.1.6. Most Common Tests Used for the Study of Uveitis
2.1.1.7. Differential Diagnosis Tables

2.1.2. Imaging Tests Used for the Study of Uveitis. Systemic Imaging Tests
2.1.3. Ophthalmological Imaging Tests. Fundus Photograph, AFG, ICG, OCT, AngioOCT, BMU, Ultrasound, etc.
2.1.4. General Treatment for Uveitis

2.1.4.1. Corticosteroids
2.1.4.2. Mydriatic and Cycloplegic Agents
2.1.4.3. Nonsteroidal Anti-Inflammatory Drugs
2.1.4.4. Immunosuppressive Treatments
2.1.4.5. New Biological Therapies to Treat Uveitis

2.1.5. Diagnostic Surgery for Uveitis. Retinal Biopsies
2.1.6. Therapeutic Surgery: Cornea, Iris, Cataracts, Glaucoma, Vitreous and Retina. Comprehensive Treatment for Uveitis

2.2. Cystoid Macular Edema

2.2.1. Pathophysiology, Blood-Retinal Barrier Function
2.2.2. Histology of Cystoid, Macular Edema
2.2.3. Rupture Mechanisms of the Blood-Retinal Barrier 
2.2.4. Exploration of Cystoid Macular Edema. Fluorescein Angiographic Patterns, OCT, OCT and Clinical in Face
2.2.5. Vitreous Fluorophotometry
2.2.6. Treatment of Post-Surgical Macular Edema

2.3. White Spot Syndromes and Associated Diseases

2.3.1. Birdshot: Chorioretinopathy in Buckshots
2.3.2. Placoid Diseases
2.3.3. Multifocal Choroiditis and Panuveitis, Internal Punctate Choroidopathy Syndrome, and Progressive Subretinal Fibrosis and Uveitis
2.3.4. Multiple Evanescent White Plaques Syndrome: Main Characteristics, Evolution and Differential Diagnosis
2.3.5. Acute Zonal External Retinopathy
2.3.6. Acute Macular Neuroretinopathy

2.4. Acute Multifocal Posterior Placoid Epitheliopathy

2.4.1. Etiopathogenesis
2.4.2. Clinical Symptoms
2.4.3. Angiographic Scanning Patterns
2.4.4. OCT, AngioOCT Scanning
2.4.5. Natural History of the Disease
2.4.6. Differential Diagnosis
2.4.7. Treatment

2.5. Serpiginous Choroiditis

2.5.1. Etiopathogenesis of Serpiginous Choroiditis
2.5.2. Clinical and Natural history of the Disease
2.5.3. Techniques for Examining Serpiginous Choroiditis
2.5.4. Angiographic Patterns and Structural OCT
2.5.5. Differential Diagnosis
2.5.6. Treatment

2.6. Vogt-Koyanagi-Harada Syndrome

2.6.1. Introduction and Classification of Vogt-Koyanagi-Harada syndrome
2.6.2. Macular Damage
2.6.3. Natural History of the Disease
2.6.4. Scanning, Angiographic Patterns, OCT Imaging. AngioOCT
2.6.5. Differential Diagnosis
2.6.6. Treatment of Associated and Recurrent Neovascular Membranes

2.7. Multifocal Choroiditis

2.7.1. Epidemiology of Multifocal Choroiditis
2.7.2. Etiopathogenesis of Multifocal Choroiditis
2.7.3. Clinical Symptoms
2.7.4. Exploration of Multifocal Choroiditis. Angiographic Patterns, ICG, OCT and Angio OCT
2.7.5. Differential Diagnosis
2.7.6. Natural History of Multifocal Choroiditis
2.7.7. Current Treatment

2.8. Sympathetic Ophthalmia

2.8.1. Epidemiology of Sympathetic Ophthalmia
2.8.2. Pathophysiology of Sympathetic Ophthalmia
2.8.3. Immunopathology of Sympathetic Ophthalmia
2.8.4. Clinical Findings
2.8.5. Scanning, Angiographic Pattern, Structural OCT and Angio OCT
2.8.6. Differential Diagnosis
2.8.7. Natural History of the Disease, Course and Possible Complications
2.8.8. Treatment, Prevention and Prognosis

2.9. Autoimmune Retinopathies

2.9.1. Epidemiology and Mechanisms of Action
2.9.2. Clinical Manifestations of Autoimmune Retinopathies
2.9.3. Diagnosis, Angiographic Patterns, OCT and AngioOCT
2.9.4. Differential Diagnosis
2.9.5. Natural History, Evolution and Possible Complications
2.9.6. Local and Systemic Treatments
2.9.7. Prognosis

2.10. Ocular Sarcoidosis

2.10.1. General Considerations in Ocular Sarcoidosis
2.10.2. Natural History and Prognosis of Ocular Sarcoidosis
2.10.3. Ocular Manifestations of Sarcoidosis
2.10.4. Posterior Segment Disease
2.10.5. Ocular Scanning, AFG Patterns, Structural OCT and OCT
2.10.6. Treatment for Retinal Sarcoidosis

2.11. Intermediate Uveitis

2.11.1. Introduction
2.11.2. Epidemiology and Demography
2.11.3. Clinical Findings, Examination of Intermediate Uveitis
2.11.4. Histopathology of Intermediate Uveitis
2.11.5. Clinical Course and Complications
2.11.6. Treatment for Intermediate Uveitis

2.12. Masquerade Syndromes

2.12.1. Malignant Uveitis Masquerade Syndromes

2.12.1.1. Intraocular Central Nervous System Lymphoma
2.12.1.2. Leukemia
2.12.1.3. Malignant Melanoma
2.12.1.4. Retinoblastoma
2.12.1.5. Metastasis
2.12.1.6. Paraneoplastic Syndromes

2.12.2. Endophthalmitis Masquerade Syndromes

2.12.2.1. Chronic Postoperative Endophthalmitis
2.12.2.2. Endogenous Endophthalmitis

2.12.3. Non-malignant and Non-infectious Masquerade Syndromes

2.12.3.1. Regmatogenic Retinal Detachment
2.12.3.2. Retinitis Pigmentosa
2.12.3.3. Intraocular Foreign Bodies
2.12.3.4. Pigmentary dispersion
2.12.3.5. Ocular Ischaemia Syndrome
2.12.3.6. Juvenile Xanthogranuloma

Module 3. Infectious Diseases of the Retina and Vitreous

3.1. General Management of Endophthalmitis

3.1.1. Medical History of the Infection Process
3.1.2. Eye Examination According to the Endophthalmitis Process
3.1.3. Sampling for Cultivation
3.1.4. Gateway and Systemic Treatment
3.1.5. Intravitreal Injection Treatment of The Endophthalmitis Process
3.1.6. Surgical Treatment for Ocular Endophthalmitis

3.2. Eye Infection Due to Human Immunodeficiency Virus (HIV)

3.2.1. Uveitis Due To HIV
3.2.2. Eye Examination in HIV Patients
3.2.3. HIV In Eyes, Chorioretinal Involvement, HIV Retinitis
3.2.4. HIV-associated opportunistic infections. Cytomegalovirus Retinitis, Varicella Zoster Virus, Ocular Toxoplasmosis, Pneumocystosis, Tuberculosis, Cryptococcosis, Candidiasis, Other Opportunistic Infections
3.2.5. Uveitis Linked to HIV Drug Treatments
3.2.6. Medical Treatment for Ocular HIV, Systemic Intravitreal and Depot Treatments
3.2.7. Surgical Treatment of HIV Retinitis or Opportunistic Infections

3.3. Mycobacterial Infections

3.3.1. Definition of Mycobacterium Tuberculosis Eye Infection
3.3.2. History and Epidemiology
3.3.3. Clinical Presentation
3.3.4. Pathophysiology of Ocular Tuberculosis
3.3.5. Pathophysiology of Ocular Tuberculosis
3.3.6. Tuberculosis Diagnostic Tests, The Tuberculin Skin Test and Other Diagnostic Tests
3.3.7. Ocular Examination, Angiographic Patterns, OCT and AngioOCT
3.3.8. Treatment of Tuberculosis and Ocular Tuberculosis
3.3.9. Possible Complications and Prognosis of Mycobacterial Infections

3.4. Spirochetal Infections

3.4.1. Definition of Treponema Pallidum Syphilis Infection
3.4.2. History and Epidemiology of Syphilis
3.4.3. Clinical Systemic Presentation
3.4.4. Ocular Clinical Presentation, Treponema Pallidum Uveitis. Anterior and Posterior Uveitis. Clinical Manifestations
3.4.5. Pathophysiology and Pathogenesis
3.4.6. Diagnostic Tests for Treponema Pallidum
3.4.7. Systemic and Ocular Treatment for Syphilis Associated Uveitis
3.4.8. Complications and Prognosis

3.5. Ocular Toxoplasmosis

3.5.1. Definition and Natural History of Toxoplasma Gondii Infection
3.5.2. Pathogenesis, the Toxoplasma Gondii Parasite
3.5.3. Parasite Life Cycle, Transmission
3.5.4. Immunobiology and Epidemiology
3.5.5. Congenital and Acquired Toxoplasmosis. Clinical Manifestations
3.5.6. Toxoplasmosis in Immunocompromised Patients
3.5.7. Diagnosis and Examination of Ocular Toxoplasmosis. Fundus photograph, AFG and ICG. OCT and AngioOCT
3.5.8. Atypical Forms of Ocular Toxoplasmosis. Angiographic and Retinographic Examination
3.5.9. Differential Diagnosis
3.5.10. Diagnostic Tests for Toxoplasma Gondii
3.5.11. Surgical Treatment for Ocular Endophthalmitis
3.5.12. Surgical Treatment of Ocular Toxoplasmosis
3.5.13. Prevention, Prognosis and Conclusions

3.6. Toxocariasis Eye Infection

3.6.1. Definition of Infection Caused by Toxocara Canis or Toxocara Cati
3.6.2. Etiology, The Micro-Organism, Its Life Cycle and Human Infection
3.6.3. Systemic and Ocular Clinical Manifestations
3.6.4. Natural History of Toxocariasis
3.6.5. Immunopathology
3.6.6. Diagnostics, Diagnostic and Serological tests
3.6.7. Ocular Complications of Toxocariasis
3.6.8. Differential Diagnosis of Toxocariasis
3.6.9. Medical and Surgical Treatment of Toxocariasis
3.6.10. Prognosis and Conclusions on Ocular Toxocariasis

3.7. Ocular Ascariasis

3.7.1. Definition of Ascaris Lumbricoides Nematode Infection
3.7.2. Natural History and Epidemiology
3.7.3. Systemic Clinical Features
3.7.4. Ocular Symptoms of Ascariasis
3.7.5. Immunology, Pathology and Pathogenesis, The Life Cycle
3.7.6. Systemic Diagnosis and Ocular Diagnosis. Basic Functional and Imaging Tests
3.7.7. Systemic Treatment and Eye Treatment
3.7.8. Possible Complications and Conclusions

3.8. Ocular Onchocerciasis

3.8.1. Definition of Onchocerca Volvulus Infection
3.8.2. Natural History, Epidemiology, Geographical Distribution
3.8.3. Demographic Factors, Ecology and Biology of Onchocerciasis
3.8.4. Systemic Clinical Manifestations of Onchocerciasis
3.8.5. Ophthalmological Symptoms of Onchocerciasis, Anterior Pole and Posterior Segment Involvement
3.8.6. Etiology, Transmission, Life Cycle of Onchocerca Volvulus
3.8.7. Pathogenesis and Pathology
3.8.8. Clinical and Laboratory Diagnostics
3.8.9. Differential Diagnosis
3.8.10. Systemic and Ocular Treatment of Onchocerciasis
3.8.11. Natural History and Prognosis

3.9. Ocular Loiasis

3.9.1. Definition of Loa Loa Filaria Infection
3.9.2. History, Epidemiology, Morphology
3.9.3. Systemic Clinical and Ocular Manifestations Anterior Pole and Posterior Pole
3.9.4. Systemic and Ocular Diagnosis
3.9.5. Systemic and Ocular Treatment
3.9.6. Prevention and Chemoprophylaxis

3.10. Ocular Cysticercosis

3.10.1. Definition of Cysticercus Cellulose Infection
3.10.2. History and Epidemiology
3.10.3. Systemic and Ocular Clinical Features
3.10.4. Pathogenesis and Pathology
3.10.5. Systemic and Ocular Diagnosis, Imaging Tests. Ultrasound
3.10.6. Differential Diagnosis
3.10.7. Treatment According to the Location of the Larvae
3.10.8. Complications and Prognosis

3.11. Ocular Borreliosis

3.11.1. Definition of Lyme Disease Due to Borrelia Burgdorferi Infection
3.11.2. History and Epidemiology
3.11.3. Systemic Clinical Symptoms According To Staging
3.11.4. Ocular Clinical Manifestations, Early Disease, Disseminated and Persistent Disease
3.11.5. Pathogenesis
3.11.6. Systemic Diagnosis and Ocular Diagnosis
3.11.7. Systemic and Ocular Treatment
3.11.8. Prognosis, Possible Complications

3.12. Bartonella Eye Infection

3.12.1. Definition of Bartonella Infections
3.12.2. History and Epidemiology
3.12.3. Systemic and Ocular Clinical Features, Retinal and Vitreous Damage
3.12.4. Pathogenesis and Immunology
3.12.5. Systemic Diagnosis and Ocular Diagnosis
3.12.6. Systemic and Ocular Treatment for Bartonellosis
3.12.7. Differential Diagnosis
3.12.8. Prognosis and Conclusions

3.13. Leptospirosis and Eye Infection

3.13.1. Definition of Leptospira Interrogans Infection
3.13.2. Epidemiology
3.13.3. Clinical Features of Non-ocular Disease
3.13.4. Clinical Signs of Leptospira Eye Disease
3.13.5. Pathogenesis
3.13.6. Laboratory Diagnostics and Ocular Diagnostics
3.13.7. Differential Diagnosis
3.13.8. Systemic and Ocular Treatment of Leptospira Infection
3.13.9. Prognosis and Conclusions

3.14. Ocular Brucellosis

3.14.1. Definition of Brucella Spp. Infection
3.14.2. History, Etiology, Epidemiology
3.14.3. Molecular Genetics, Pathology and Immunology
3.14.4. Systemic Clinical features, Subclinical, Acute, Subacute and Chronic Disease
3.14.5. Ocular Manifestations
3.14.6. Systemic and Ocular Diagnosis
3.14.7. Systemic and Ocular Treatment for Bartonellosis
3.14.8. Prognosis, Prevention and Conclusions

3.15. Ocular Whipple's Disease

3.15.1. Definition Signs of Leptospira Eye Disease
3.15.2. History, Epidemiology, Etiology, Pathology and Immunology
3.15.3. Extraocular Clinical Features
3.15.4. Ocular Clinical Features, Uveitis, Neurophthalmology
3.15.5. Systemic and Ocular Diagnosis
3.15.6. Differential Diagnosis
3.15.7. Systemic and Ocular Medical Treatment. Surgical Management
3.15.8. Prognosis and Conclusions

3.16. Rickettsial Eye Disease

3.16.1. Definition, Microbiological Characteristics and Classification of Rickettsioses
3.16.2. History. Epidemiology. Pathophysiology. Immunology. Pathology and Pathogenesis
3.16.3. Clinical Characteristics. Systemic and Ocular Involvement
3.16.4. Systemic, laboratory and ocular diagnosis
3.16.5. Systemic and Ocular Treatment
3.16.6. Prognosis, Complications and Conclusions on Ocular Rickettsiosis

3.17. Eye Leprosy

3.17.1. Definition of Ocular Hansen's Disease Caused by Mycobacterium Leprae
3.17.2. History and Epidemiology
3.17.3. Systemic and Ocular Clinical Features
3.17.4. Posterior Segment Ocular Complications. Ocular Changes During Acute Leprosy Reactions
3.17.5. Ocular Histopathology
3.17.6. Pathogenesis and Immunology
3.17.7. Systemic and Ocular Diagnosis
3.17.8. Differential Diagnosis
3.17.9. Treatment of Systemic Disease and Eye Disease
3.17.10. Management of Ocular Complications

3.18. Herpes Virus Eye Infections

3.18.1. Virology, Herpes Simplex Virus and Varicella Zoster Virus

3.18.1.1. Clinical Features, Acute Retinal Necrosis and Other Retinopathies
3.18.1.2. Diagnostics, Functional and Imaging tests, AFG, OCT and OCT
3.18.1.3. Differential Diagnosis of Acute Retinal Necrosis
3.18.1.4. Treatment of Acute Retinal Necrosis, Antiviral Agents. Treatment of Associated Retinal Detachment

3.18.2. Eye Infection Due to Epstein-Barr Virus
3.18.3. Cytomegalovirus Eye Infections

3.18.3.1. Ocular Clinical Features
3.18.3.2. Systemic and Ocular Treatment
3.18.4.3. Complications, Prognosis and Conclusions of Cytomegalovirus Infection

3.19. Rubella Eye Disease. Measles Disease

3.19.1. Definition of Measles or Rubella Disease
3.19.2. History
3.19.3. Congenital Rubella
3.19.4. Acquired Rubella
3.19.5. Subacute Sclerosis Subacute Panencephalitis
3.19.6. Treatment for Ocular Rubella
3.19.7. Prognosis and Conclusions

3.20. Presumptive Ocular Histoplasmosis Syndrome

3.20.1. Definition
3.20.2. History, Mycology and Epidemiology
3.20.3. Clinical Features, Disseminated choroiditis, Maculopathy
3.20.4. Pathogenesis, Pathophysiology, Immunology
3.20.5. Laboratory Diagnostics and Ocular Diagnostics, Imaging Tests
3.20.6. Differential Diagnosis
3.20.7. Laser Treatment, Corticosteroid Treatment and Other Currently Proposed Treatments
3.20.8. Submacular and Subretinal Surgery. Complications
3.20.9. Prognosis and Conclusions

3.21. Ocular Candidiasis

3.21.1. Definition of Candida Eye Infection
3.21.2. History and Epidemiology
3.21.3. Clinical Features, Endogenous and Exogenous Candida Endophthalmitis
3.21.4. Complications, Pathogenesis, Histopathology and Immunology
3.21.5. Diagnosis. Vitreous and Anterior Chamber Aspiration
3.21.6. Differential Diagnosis
3.21.7. Systemic and Medical Treatment. The Role of Vitrectomy
3.21.8. Prognosis and Conclusions

3.22. Ocular Amebiasis

3.22.1. Definition of Acanthamoeba and Naegleria Eye Infection
3.22.2. History and Microbiology
3.22.3. Epidemiology, Pathophysiology
3.22.4. Clinical Ocular Disease, Anterior Pole, Uveitis and Late Complications
3.22.5. Diagnostics, Confocal Microscopy, Laboratory Diagnostics
3.22.6. Histology, Cultures
3.22.7. Differential Diagnosis
3.22.8. Medical Treatment, The Value of Vitrectomy and Cryotherapy
3.22.9. Prevention, Prognosis and Conclusions

A unique, key, and decisive educational experience to boost your professional development”